Radioimmunotherapy of fungal diseases: The therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens

Frontiers in Microbiology

Volumn 2, Issue JAN, 2012, Pages

  Nosanchuk, Joshua D ^a   Dadachova, Ekaterina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody; Beta glucan; Candida albicans; Cryptococcus neoformans; Heat shock protein 60; Histoplasma capsulatum; Melanin

Indexed keywords

AJELLOMYCES CAPSULATUS; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 84875773694     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00283     Document Type: Review

References (40)

1. Behr, T. M., Béhé, M., Stabin, M. G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., Koch, L., Goldenberg, D. M., and Becker, W. (1999). High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi-versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res. 59,2635-2643.
2. Bryan, R., Jiang, Z., Friedman, M., and Dadachova, E. (2011). The effects of gamma radiation, UV and visible light on ATP levels in yeast cells depend on cellular melanization. Fungal Biol. 115, 945-949.
3. Bryan, R. A., Guimaraes, A. J., Hopcraft, S., Jiang, Z., Bonilla, K., Morgenstern, A., Bruchertseifer, F., Del Poeta, M., Torosantucci, A., Cassone, A., Nosanchuk, J. D., Casadevall, A., and Dadachova, E. (2011). Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Myco-pathologia. doi: 10.1007/s11046-011-9476-9. [Epub ahead of print].
4. Bryan, R. A., Huang, X., Morgenstern, A., Bruchertseifer, F., Casadevall, A., and Dadachova, E. (2008). Radiofungicidal effects of external gamma radiation and antibody-targeted beta and alpha radiation on Cryptococcus neoformans. Antimicrob. Agents Chemother. 52, 2232-2235.
5. Bryan, R. A., Jiang, Z., Howell, R. C., Morgenstern, A., Bruchertseifer, E, Casadevall, A., and Dadachova, E. (2010). Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection. J. Infect. Dis. 202, 633-637.
6. Bryan, R. A., Jiang, Z., Huang, X., Morgenstern, A., Bruchertseifer, F., Sellers, R., Casadevall, A., and Dadachova, E. (2009). Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells. Antimicrob. Agents Chemother. 53, 1679-1682.
7. Casadevall, A., Goldstein, H., and Dadachova, E. (2007). Targeting host cells harbouring viruses with radio-labeled antibodies. Expert Opin. Biol. Ther. 7, 595-597.
8. Caston-Osorio, J. J., Rivero, A., and Torre-Cisneros, J. (2008). Epidemiology of invasive fungal infection. Int. J. Antimicrob. Agents 32(Suppl. 2),S103-S109.
9. Dadachova, E., Bryan, R. A., Howell, R. C., Schweitzer, A. D., Aisen, P., Nosanchuk, J. D., and Casadevall, A. (2008). The radioprotective properties of fungal melanin are a function of its chemical composition, stable radical presence and spatial arrangement. Pigment Cell Melanoma Res. 21, 192-199.
10. Dadachova, E., Burns, T., Bryan, R. A., Apostolidis, C., Brechbiel, M. W., Nosanchuk, J. D., Casadevall, A., and Pirofski, L. (2004). Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob. Agents Chemother. 48, 1624-1629.
11. Dadachova, E., Bryan, R. A., Frenkel, A., Zhang, T., Apostolidis, C., Nosanchuk, J. S., Nosanchuk, J. D., and Casadevall, A. (2004). Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models. Antimicrob. Agents Chemother. 48,1004-1006.
12. Dadachova, E., Nakouzi, A., Bryan, R. A., and Casadevall, A. (2003). Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc. Natl. Acad. Sci. U.S.A. 20, 20.
13. Dadachova, E., Patel, M. C., Tou-ssi, S., Apostolidis, C., Morgenstern, A., Brechbiel, M. W., Gorny, M. K., Zolla-Pazner, S., Casadevall, A., and Goldstein, H. (2006). Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med. 3, e427. doi:10.1371/journal.pmed.0030427
14. Dadachova, E., Bryan, R. A., Apostolidis, C., Morgenstern, A., Zhang, T., Moadel, T., Torres, M., Huang, X., Revskaya, E., and Casadevall, A. (2006). Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. J. Infect. Dis. 193, 1427-1436.
15. Dadachova, E., Wang, X. G., and Casadevall, A. (2007). Targeting the virus with radioimmunotherapy in virus-associated cancers. Cancer Biother. Radiopharm. 22, 303-308.
16. Guimaraes, A. J., Frases, S., Gomez, F. J., Zancope-Oliveira, R. M., and Nosanchuk, J. D. (2009). Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect. Immun. 77, 1357-1367.
17. Harris, M., Wang, X. G., Jiang, Z., Goldberg, G. L., Casadevall, A., and Dadachova, E. (2011). Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol. 3,9.
18. Macklis, R. M. (2004). How and why does radioimmunotherapy work? Int. J. Radiat. Oncol. Biol. Phys. 59, 1269-1271.
19. Macklis, R. M., and Pohlman, B. (2006). Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists. Int. J. Radiat. Oncol. Biol. Phys. 66, 833-841.
20. Martinez, L. R., Bryan, R. A., Apostolidis, C., Morgenstern, A., Casadevall, A., and Dadachova, E. (2006). Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrob. Agents Chemother. 50, 2132-2136.
21. Mednick, A. J., Nosanchuk, J. D., and Casadevall, A. (2005). Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect. Immun. 73,2012-2019.
22. Nosanchuk, J. D., and Casadevall, A. (2006). Impact of melanin onmicro-bial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 50, 3519-3528.
23. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530.
24. Patterson, T. F. (2005). Advances and challenges in management of invasive mycoses. Lancet 366, 1013-1025.
25. Pfaller,M.A.,andDiekema,D. J. (2010). Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36, 1-53.
26. Phaeton, R., Harris, M., Jiang, Z., Wang, X. G., Einstein, M. H., Goldberg, G. L., Casadevall, A., and Dadachova, E. (2010). Radioimmunotherapy with an antibody to the HPV16 E6 onco-protein is effective in an experimental cervical tumor expressing low levels of E6. Cancer Biol. Ther. 10, 1041-1047.
27. Phaeton, R., Wang, X. G., Einstein, M. H., Goldberg, G. L., Casadevall, A., and Dadachova, E. (2010). The influence of protea-some inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice. Cancer 116(4 Suppl.), 1067-1074.
28. Rachini, A., Pietrella, D., Lupo, P., Torosantucci, A., Chiani, P., Bro-muro, C., Proietti, C., Bistoni, F., Cassone, A., and Vecchiarelli, A. (2007). An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect. Immun. 75, 5085-5094.
29. Rhome, R., Singh, A., Kechichian, T., Drago, M., Morace, G., Luberto, C., and Del Poeta, M. (2011). Surface localization of glucosylce-ramide during Cryptococcus neoformans infection allows targeting as a potential antifungal. PLoS ONE 6, e15572. doi:10.1371/jour-nal.pone.0015572
30. Richardson, M., and Lass-Florl, C. (2008). Changing epidemiology of systemic fungal infections. Clin. Microbiol. Infect. 14(Suppl. 4), 5-24.
31. Rivera, J., Nakouzi, A., Abboud, N., Revskaya, E., Goldman, D., Collier, R. J., Dadachova, E., and Casadevall, A. (2006). A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epi-tope in domain 1. Infect. Immun. 74, 4149-4156.
32. Rivera, J., Nakouzi, A. S., Morgenstern, A., Bruchertseifer, F., Dadachova, E., and Casadevall, A. (2009). Radiolabeled antibodies to Bacillus anthracis toxins are bactericidal and partially therapeutic in experimental murine anthrax. Antimicrob. Agents Chemother. 53, 4860-4868.
33. Rosas, A. L., Nosanchuk, J. D., Feldmesser, M., Cox, G. M., McDade, H. C., and Casadevall, A. (2000). Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect. Immun. 68, 2845-2853.
34. Sharkey, R. M., Blumenthal, R. D., Behr, T. M., Wong, G. Y., Haywood, L., Forman, D., Griffiths, G. L., and Goldenberg, D. M. (1997). Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int. J. Cancer 72, 477-485.
35. Shen, S., Duan, J., Meredith, R. F., Buchs-baum, D. J., Brezovich, I. A., Pareek, P. N., and Bonner, J. A. (2002). Model prediction of treatment planning for dose-fractionated radioimmunotherapy. Cancer 94(4 Suppl.), 1264-1269.
36. Taborda, C. P. , Da Silva, M. B., Nosanchuk, J. D., and Travassos, L. R. (2008). Melanin as a virulence factor of Paracoccidioides brasilien-sis and other dimorphic pathogenic fungi: a minireview. Mycopathologia 165,331-339.
37. Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., Rappuoli, R., and Cassone, A. (2005). A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202, 597-606.
38. Torosantucci, A., Chiani, P., Bromuro, C., De Bernardis, F., Palma, A. S., Liu, Y., Mignogna, G., Maras, B., Colone, M., Stringaro, A., Zamboni, S., Feizi, T., and Cassone, A. (2009). Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE 4, e5392. doi:10.1371/journal.pone. 0005392
39. Wang, X. G., Revskaya, E., Bryan, R. A., Strickler, H. D., Burk, R. D., Casadevall, A., and Dadachova, E. (2007). Treating cancer as an infectious disease - viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology. PLoS ONE 2, e1 114. doi:10.1371/journal.pone.0001114
40. Zhong, Z., Burns, T., Chang, Q., Carroll, M., and Pirofski, L. (1999). Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide. Infect. Immun. 67, 4119-4127.